FIU IRB Approval:   12/12/2018  
FIU IRB Expi[INVESTIGATOR_1516]:   12/12/2019  
FIU IRB Number:      IRB-18-[ADDRESS_681379] 
of different types of  pi[INVESTIGATOR_525061] .  
 
NUMBER OF STUDY PARTICIPANTS  
If you decide to be in this study, you will be one of 40 people in this research study.  
 
DURATION OF THE STUDY  
Your participation will require four interactions  with research students, including, three face to face 
visits. Full participation in the study is anticipated to take no longer than 5 hours total across all 
interactions.  
 
PROCEDURES  
If you agree to be in the study, there will be a total of four interacti ons lasting approximately 5 hours 
over the course of approximately 3 months.   If you agree to be in the study, we will ask you to do the 
following things:  
1. Describe your background, health, medications, and daily routines related to talking medication 
in a series of audio recorded interviews and surveys.  
2. Use a new pi[INVESTIGATOR_525062] 1 month.  
 
RISKS AND/OR DISCOMFORTS  
The following risks may be associated with your participation in this study:  
 Loss of time  – This study will take approximately 5 hours  of your time.  
 Boredom  – You will be asked to complete a series of surveys and interviews, which some 
people may find boring.  
 Invasion of privacy – Some of the interview and survey question may ask about your health 
and medications.  
 Leakage of information  – We store the information on computers and filing cabinets. While 
we do everything, we can to protect the data, there is always a risk of a data breach.  
 Medication errors – In this study you will use a new pi[INVESTIGATOR_61194]. This may make you more likely 
to make a  medication error. We will go over the new pi[INVESTIGATOR_525063] a medication error.  
 
BENEFITS  
The following benefits may be associated with yo ur participation in this study: First, you  will receive 
a new pi[INVESTIGATOR_61194]. Second, your participation in this study will help us learn more about medication 
adherence and help us help others better take their medications as prescribed. Finally, you may enjoy 
sharing your story with the research team.  
 
ALTERNATIVES  
There are no known alternatives available to you other than not taking part in this study.    

FIU IRB Approval:   12/12/2018  
FIU IRB Expi[INVESTIGATOR_1516]:   12/12/2019  
FIU IRB Number:      IRB-18-[ADDRESS_681380], or harming yourself or others.  
   
COMPENSATION & COSTS  
You will receive a payment of  up to $[ADDRESS_681381]., AHC 3, 420 -A, 
Miami, FL [ZIP_CODE], (305) 348 - 3106, [EMAIL_10019].   
 
IRB CONTA CT INFORMATION  
If you would like to talk with someone about your rights of being a subject in this research study or 
about ethical issues with this research study, you may contact [CONTACT_525064] 305 -348-2494 or by [CONTACT_25541]  [EMAIL_10020].  
 
PARTICIPANT AGREEMENT  
I have read the information in this consent form and agree to participate in this study.  I have had a 
chance to ask any questions I have about this study, and they have been answered for me.  I 
understand that I will be given a copy of this form for my records.  
 
________________________________           __________________  
Signature [CONTACT_295217]  
 
________________________________  
Printed Name [CONTACT_2385]  
 
________________________________     ____________ ______  
Signature [CONTACT_525065]  